Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

Super Bowl LIX kicks off on Sunday. What number is that, though? Here's how to use Roman numerals and why the NFL uses them ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...

GSK PLC GSK shares slid 2.47% to £14.43 Friday, on what proved to be an all-around dismal trading session for the stock ...

MicroStrategy, the business intelligence firm and Bitcoin treasury company co-founded by Michael Saylor has rebranded to ...

GSK PLC closed 18.56% below its 52-week high of £18.24, which the company reached on May 16th.

The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...